J Juncos, C Serrati, G Fabbrini, T N Chase. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Delayed-Action PreparationsHumansLevodopa/administration & dosageLevodopa/bloodParkinson Disease/bloodParkinson Disease/drug therapy
Substances: See more » Delayed-Action PreparationsLevodopa
Year: 1985 PMID: 2863459 DOI: 10.1016/s0140-6736(85)92754-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321